Abstract:Ghrelin is an orexigenic hormone. Circulating levels normally rise between episodes of food ingestion and then fall upon eating. Ghrelin may also be a signal to prime the gut for nutrient absorption. An anti-inflammatory role has also been proposed. A single previous report has suggested an increase in plasma fasting acylated ghrelin expression in active inflammatory bowel disease (IBD), with levels returning to normal once the disease is in remission. The postprandial response of ghrelin in intestinal inflammation has never been described. 21 patients with active Crohn's disease (CD) and 12 healthy controls were recruited. Disease activity was classified through independent histopathological/endoscopic assessments, validated patient questionnaires and biochemical scores. Gut hormone responses to a mixed nutrient test meal were studied using a multiplex ELISA technique (Luminex). Patient symptoms were assessed using a validated visual analogue score (VAS). A subgroup of patients who achieved remission (without surgery or anti-TNFα treatment) was also re-studied later. CD patients with active inflammation displayed a ∼6-fold significant reduction in basal appetite parameters as measured by VAS (p < 0.0001). The pattern of the postprandial ghrelin response was paradoxically altered in the CD group with a rise noted postprandially. In the control group ghrelin levels displayed the expected drop after the test meal. Consequently, acylated ghrelin levels were higher in the CD group with a 3-fold increase noted in the total ghrelin level after the test meal. A significant correlation (p = 0.019) was noted between the total acetylated ghrelin secreted and the Crohn's Disease Activity Index. A significant correlation also existed between ghrelin secretion and stool frequency (p = 0.01), more so in the SB CD group (p = 0.004). There was a significant negative correlation noted between the abdominal pain scores in the visual analogue score specifically in the SB CD group (p = 0.0008). After treatment of CD, the VAS reverted to those of normal controls and ghrelin responses to the test meal now showed a postprandial fall, as expected physiologically. Ghrelin levels show an unexpected rise in response to a test meal in ileal CD. Ghrelin is not expressed in the healthy distal small bowel. It is now necessary to explore whether inflammation induces its expression there, or whether gastric secretion of ghrelin is somehow amplified at a distance. In intestinal inflammation, it may be that ghrelin assumes more its secondary role, that of an anti-inflammatory peptide. This plays a protective role when the antigen load of a meal is presented to the inflamed gut. The changes noted after treatment tend to corroborate this. Its postprandial response may also present a useful novel biomarker of disease activity.

Plasma bile acids in association with Crohn's disease

Bile Acids and Microbiota: Multifaceted and Versatile Regulators of the Liver–Gut Axis

The relationship between fecal bile acids and microbiome community structure in pediatric Crohn’s disease

Inflammatory Bowel Disease Associated with Primary Sclerosing Cholangitis is Associated with an Altered Gut Microbiome and Bile Acid Profile

P369 Altered fecal bile acid composition in active Ulcerative Colitis

Altered FXR signalling is associated with bile acid dysmetabolism in short bowel syndrome-associated liver disease

Plasma Levels of Bile Acids Are Related to Cardiometabolic Risk Factors in Young Adults

P912 Increased Primary Bile Acids with Ileocolonic Resection Impact Ileal Inflammation and Gut Microbiota in Inflammatory Bowel Disease

Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.

Altered profiles of fecal bile acids correlate with gut microbiota and inflammatory responses in patients with ulcerative colitis

Bile acid alterations associated with indolent course of inflammatory bowel disease

The interaction of bile acids and gut inflammation influences the pathogenesis of inflammatory bowel disease

Fecal deoxycholic acid associates with diet, intestinal microbes, and total bilirubin in primary sclerosing cholangitis

The relative abundance of fecal bacterial species belonging to the Firmicutes and Bacteroidetes phyla is related to plasma levels of bile acids in young adults

Serum Analyte Profiles Associated With Crohn's Disease and Disease Location

Intestinal barrier biomarkers in clinical evaluation of patients with inflammatory bowel disease

CRP in Outpatients with Inflammatory Bowel Disease Is Linked to the Blood Microbiota

P179 Decrease in Butyric Acid in fecal matter in patients with Inflammatory Bowel Disease is associated with the levels of secretory Immunoglobulin A and fecal calprotectin

Evaluation of gut dysbiosis using serum and fecal bile acid profiles

Unique bile acid profiles in the bile ducts of patients with primary sclerosing cholangitis

Plasma Ghrelin paradoxically rises upon feeding in active Crohn's disease